Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-14 Option Award |
2023-02-16 6:22 pm |
N/A 2033-02-13 |
IMPEL PHARMACEUTICALS INC | IMPL | Hoekman John Chief Scientific Officer |
42,500 | $0 | 42,500 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 5:03 pm |
N/A 2032-01-25 |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:50 pm |
N/A 2021-12-22 |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
20,000 | $0 | 128,221 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:50 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
20,000 | $1.64 | 128,221 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-26 5:58 pm |
N/A 2031-07-19 |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-04-27 Conversion(A) |
2021-06-07 4:57 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
73,910 | $0 | 108,496 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
74,180 | $0 | 178,153 (Direct) |
View |
| 2021-04-27 Other |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
275 | $0 | 178,153 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
8,523 | $8.19 | 178,153 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-29 6:31 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
8,523 | $0 | 178,153 (Direct) |
View |
Ownership |
2021-04-22 7:04 pm |
N/A N/A |
IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer |
0 | $0 | 556,104 (Direct) |
View |